ENCELADUS BIO

Welcome to the Brand page for “ENCELADUS BIO”, which is offered here for Pharmaceutical and biological preparations based on genome editing and engineering for use in human therapeutics;medical and scientific research information in the field of genome editing and engineering, gene modulation, gene repair, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; pharmaceutical research and development; pharmaceutical research services; providing medical research and scientific research information in the fields of genome editing and engineering, gene modulation, gene repair, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy;.

Its status is currently believed to be active. Its class is unavailable. “ENCELADUS BIO” is believed to be currently owned by “FirstLight Bio, Inc.”